Lymphoma Research Foundation awards over $5.7M in grants

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Lymphoma Research Foundation awarded 29 grants, totaling more than $5.7 million, to support lymphoma research. The 2022 LRF grantee class represents 17 academic and medical institutions across North America.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Citius Oncology announced positive topline safety and efficacy results from an investigator‑initiated phase I trial evaluating Lymphir (E7777, denileukin diftitox‑cxdl) administered prior to commercial CD19‑directed CAR T therapy in patients with high‑risk relapsed or refractory diffuse large B‑cell lymphoma. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login